New Journey Health Technology Group Co.,LTD (SHE:002219)
China · Delayed Price · Currency is CNY 2.090
+0.010 (0.48%)
Aug 3, 2026, 3:04 PM CST
SHE:002219 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,977 | 3,053 | 3,799 | 3,914 | 3,161 | 3,016 |
Revenue Growth | -18.27% | -19.64% | -2.94% | 23.83% | 4.80% | 7.49% |
Gross Profit Gross Profit Growth | 872.77 | 875.47 | 1,176 | 1,173 | 992.42 | 807.44 |
Operating Income Operating Income Growth | 198.54 | 204.78 | 307.21 | 176.87 | 229.91 | -35.56 |
Net Income Net Income Growth | 25.76 | 30.94 | 114.77 | 28.97 | 156.12 | -371.43 |
Earnings Per Share EPS Growth | 0.01 | 0.01 | 0.03 | 0.01 | 0.05 | -0.20 |
EPS Growth | -77.17% | -73.07% | 292.13% | -81.38% | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceuticals and medical products Pharmaceuticals and medical products Growth | 433.65 | 753.33 | 783.27 | 491.69 | 461.17 |
Medical and Health Care Services Medical and Health Care Services Growth | 2,652 | 3,019 | 3,120 | 2,642 | 2,532 |
Health and Wellness Industry Health and Wellness Industry Growth | - | 26.55 | - | - | - |
Intersegment Offset Intersegment Offset Growth | -181.66 | - | - | - | - |
Parent company and investment companies Parent company and investment companies Growth | 148.92 | - | - | - | - |
Total Total Growth | 3,053 | 3,799 | 3,904 | 3,161 | 3,016 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 251.56 | 396.35 | 478.09 | 601 | 559.38 | 2,033 |
Total Debt Total Debt Growth | 1,413 | 1,905 | 1,971 | 2,404 | 1,288 | 1,953 |
Net Cash (Debt) Net Cash Growth | -1,162 | -1,508 | -1,493 | -1,803 | -728.45 | 80.15 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.35 | -0.46 | -0.45 | -0.55 | -0.22 | 0.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 318.91 | 293.79 | 438.51 | 320.93 | 268.04 | 277.29 |
Capital Expenditures CapEx Growth | -198.18 | -257 | -307.44 | -209.68 | -221.58 | -198.73 |
Free Cash Flow Free Cash Flow Growth | 120.73 | 36.78 | 131.06 | 111.25 | 46.47 | 78.56 |
Free Cash Flow Growth | 215.86% | -71.94% | 17.81% | 139.42% | -40.86% | 16.87% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 29.32% | 28.68% | 30.97% | 29.96% | 31.40% | 26.77% |
Operating Margin | 6.67% | 6.71% | 8.09% | 4.52% | 7.27% | -1.18% |
Pretax Margin | 2.50% | 2.55% | 4.06% | 0.28% | 5.93% | -12.02% |
Profit Margin | 0.86% | 1.01% | 3.02% | 0.74% | 4.94% | -12.31% |
FCF Margin | 4.06% | 1.21% | 3.45% | 2.84% | 1.47% | 2.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 266.56 | 232.49 | 77.69 | 356.71 | 82.38 | - |
Forward PE | - | 59.75 | 59.75 | 59.75 | 59.75 | 59.75 |
P/FCF Ratio | 59.30 | 195.58 | 68.03 | 92.90 | 276.78 | 86.89 |
PS Ratio | 2.41 | 2.36 | 2.35 | 2.64 | 4.07 | 2.26 |